Eli Lilly has announced results from the VIVID-2 open-label extension study, showing that most patients with moderately to ...
The administration officer will be a key member of the Inflammatory Bowel Disease (IBD) team, working alongside the IBD clinical nurse consultants (IBDCNC) and Nurse Practitioner (NP) providing ...
The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback